Workplan Contents. The goal of the Workplan and the Program will be to evaluate and produce LNP formulations that are safe and efficacious for delivery of Scribe’s Genome Editing Constructs and to advance the development of such Genome Editing Construct-LNP formulations as [*]. All activities using Acuitas LNP Technology will be limited to Reserved Targets and will be only as set forth in the Workplan. The Workplan will include [*].
Appears in 2 contracts
Sources: Development and Option Agreement (Scribe Therapeutics, Inc.), Development and Option Agreement (Scribe Therapeutics, Inc.)